Dayal Sujata Tyagi, a director at Emergent BioSolutions Inc. ($EBS), made one open market sale of common shares in the last 365 days, totaling $85,520. Her most recent sale occurred on November 7, 2025. This ranks her 9,788th out of 11,678 insiders by sale value, well below the average of $8.6 million across 6.37 transactions per insider. She reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 7, 2025 | Emergent BioSolutions Inc. | $EBS | Dayal Sujata Tyagi | Director | S | Common Stock | 8552 | $10.00 | 88,980.0000 | 56,700,000 | 8.77% | 0.02% |
| April 30, 2025 | Emergent BioSolutions Inc. | $EBS | Dayal Sujata Tyagi | Director | A | Common Stock | 34403 | $0.00 | 97,532.0000 | 53,000,000 | 54.50% | 0.06% |
| April 30, 2025 | Emergent BioSolutions Inc. | $EBS | Dayal Sujata Tyagi | Director | A | Stock Option (Right to Buy) | 15824 | $0.00 | 41,572.0000 | 53,000,000 | 61.46% | 0.03% |
| May 23, 2024 | Emergent BioSolutions Inc. | $EBS | Dayal Sujata Tyagi | Director | A | Common Stock | 17430 | $0.00 | 63,129.0000 | 51,200,000 | 38.14% | 0.03% |
| May 23, 2024 | Emergent BioSolutions Inc. | $EBS | Dayal Sujata Tyagi | Director | A | Stock Option (Right to Buy) | 25748 | $0.00 | 25,748.0000 | 51,200,000 | 9999.99% | 0.05% |